# RevMed RMC-6236-304

> Medical

Canonical page: [https://chrome-stats.com/d/id6754037804](https://chrome-stats.com/d/id6754037804)

## Overview

- **ID:** `id6754037804`
- **Platform:** Apple
- **Type:** Apple app
- **Status:** Available
- **Publisher:** ERT,INC
- **Category:** Medical
- **Version:** 2.21.4 (39)
- **Last updated:** 2026-07-01
- **First published:** 2025-11-26
- **Size:** 86 MB
- **Data as of:** 2026-09-06
- **Store listing:** [Apple App Store](https://apps.apple.com/us/app/revmed-rmc-6236-304/id6754037804)
- **Website:** [https://Clario.com/](https://clario.com/)
- **Privacy policy:** [https://clario.com/about/legal-and-privacy/](https://clario.com/about/legal-and-privacy/)

## Description

Revolution Medicines RASolute 304 Clinical Assessments. App is intended to collect patient reported outcomes relating to the RASolute 304 (RMC-6236-304) clinical trial.

Revolution Medicines RASolute 304 Clinical Assessments App is intended to collect patient reported outcomes relating to the RASolute 304 (RMC-6236-304) clinical trial. Patients must be given accounts by a participating site in order to log in to the app.

## Rankings

- #1,548,648 — Overall

## Similar extensions and apps

- [RevMed RMC-6236-303](https://chrome-stats.com/d/id6759459169)
- [RAP-219-FOS-301](https://chrome-stats.com/d/id6757742140)
- [RAP-219-FOS-901](https://chrome-stats.com/d/id6753101018)
- [RAP-219-FOS-302](https://chrome-stats.com/d/id6758348205)
- [Vor Biopharma - RC18G007](https://chrome-stats.com/d/id6760748308)
- [CRYS-301\_302](https://chrome-stats.com/d/id6742195649)
- [Amgen 20240113](https://chrome-stats.com/d/id6753682886)
- [C4 Therapeutics-CFT7455-2101](https://chrome-stats.com/d/id6756125914)
- [PHA022121-C303](https://chrome-stats.com/d/id6657974553)
- [JNJ\_77242113CRD3001](https://chrome-stats.com/d/id6746571737)
- [CSL300\_2301\_Ph3](https://chrome-stats.com/d/id6475711776)
- [Insmed - INS1202-101](https://chrome-stats.com/d/id6755458629)

---

Source: [Chrome-Stats](https://chrome-stats.com/d/id6754037804)
